[go: up one dir, main page]

WO2004056264A1 - Affichage graphique pour dispositifs medicaux - Google Patents

Affichage graphique pour dispositifs medicaux Download PDF

Info

Publication number
WO2004056264A1
WO2004056264A1 PCT/DK2003/000912 DK0300912W WO2004056264A1 WO 2004056264 A1 WO2004056264 A1 WO 2004056264A1 DK 0300912 W DK0300912 W DK 0300912W WO 2004056264 A1 WO2004056264 A1 WO 2004056264A1
Authority
WO
WIPO (PCT)
Prior art keywords
display
blood glucose
future
past
cbgm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2003/000912
Other languages
English (en)
Inventor
Jens Aage Munk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority to AU2003287925A priority Critical patent/AU2003287925A1/en
Publication of WO2004056264A1 publication Critical patent/WO2004056264A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays

Definitions

  • Figure 1c shows that the level has been relatively stable at a high level within the last hour.
  • the concentration is increasing and above the critical level, so the color is red.
  • Figure 1e shows the opposite situation depicted in Figure 1d.
  • Figures 3a-3f illustrate a different embodiment, where the present time is displayed numeri- cally and the blood glucose level, or other parameter of interest, is displayed graphically. This display also shows other information such as battery power, indicated on the right side of the display.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

L'invention concerne un affichage graphique destiné à un appareil de surveillance médicale. Cet affichage comprend des moyens graphiques permettant d'afficher les valeurs passées, les valeurs présentes et les valeurs futures prédites. L'affichage peut en outre présenter des données représentatives d'une tendance, et indiquer si l'état d'un patient ou un paramètre surveillé présente une amélioration. L'affichage peut être graphique ou comprendre une combinaison d'éléments graphiques et de texte. Des couleurs, des clignotements, des ombres ou des flèches en mouvement peuvent illustrer diverses informations et les transmettre à un patient utilisant l'affichage. Cet affichage convient pour divers dispositifs, notamment pour les appareils de mesure en continu de la glycémie. Dans certaines formes de réalisation, l'affichage est solidaire des moyens de surveillance et dans d'autres formes de réalisation, notamment les dispositifs à dérivation, l'affichage sera utilisé sur un moniteur raccordé au capteur ou communiquant d'une autre manière avec ce dernier et mesurant l'état du patient. Dans certaines formes de réalisation, le capteur peut être disposé sur le patient à distance de l'affichage, et communiquer avec un processeur raccordé à un moniteur équipé de l'affichage décrit.
PCT/DK2003/000912 2002-12-19 2003-12-19 Affichage graphique pour dispositifs medicaux Ceased WO2004056264A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003287925A AU2003287925A1 (en) 2002-12-19 2003-12-19 Graphical display for medical devices

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43455902P 2002-12-19 2002-12-19
US60/434,559 2002-12-19
DKPA200300154 2003-02-04
DKPA200300154 2003-02-04

Publications (1)

Publication Number Publication Date
WO2004056264A1 true WO2004056264A1 (fr) 2004-07-08

Family

ID=32683723

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2003/000912 Ceased WO2004056264A1 (fr) 2002-12-19 2003-12-19 Affichage graphique pour dispositifs medicaux

Country Status (2)

Country Link
AU (1) AU2003287925A1 (fr)
WO (1) WO2004056264A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD611151S1 (en) 2008-06-10 2010-03-02 Lifescan Scotland, Ltd. Test meter
USD612274S1 (en) 2008-01-18 2010-03-23 Lifescan Scotland, Ltd. User interface in an analyte meter
US8917184B2 (en) 2008-03-21 2014-12-23 Lifescan Scotland Limited Analyte testing method and system
EP4601218A3 (fr) * 2010-10-27 2025-11-19 DexCom, Inc. Dispositif d'enregistrement continu de données de surveillance de substance à analyser pouvant fonctionner en mode aveugle

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
WO2000018293A1 (fr) * 1997-01-10 2000-04-06 Health Hero Network, Inc. Systeme de traitement du diabete et methode de controle de la glycemie
WO2003057027A2 (fr) * 2001-12-27 2003-07-17 Medtronic Minimed, Inc. Systeme de controle de caracteristiques physiologiques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
WO2000018293A1 (fr) * 1997-01-10 2000-04-06 Health Hero Network, Inc. Systeme de traitement du diabete et methode de controle de la glycemie
WO2003057027A2 (fr) * 2001-12-27 2003-07-17 Medtronic Minimed, Inc. Systeme de controle de caracteristiques physiologiques

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD612274S1 (en) 2008-01-18 2010-03-23 Lifescan Scotland, Ltd. User interface in an analyte meter
US8917184B2 (en) 2008-03-21 2014-12-23 Lifescan Scotland Limited Analyte testing method and system
US9626480B2 (en) 2008-03-21 2017-04-18 Lifescan Scotland Limited Analyte testing method and system
USD611151S1 (en) 2008-06-10 2010-03-02 Lifescan Scotland, Ltd. Test meter
EP4601218A3 (fr) * 2010-10-27 2025-11-19 DexCom, Inc. Dispositif d'enregistrement continu de données de surveillance de substance à analyser pouvant fonctionner en mode aveugle

Also Published As

Publication number Publication date
AU2003287925A1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
US20040153257A1 (en) Graphical display for medical devices and methods for displaying medical information
US12440173B2 (en) Displays for a medical device
US8577433B2 (en) Medical device alarm modeling
CN101460086B (zh) 缓解的趋势和预期趋势的显示
US20220248988A1 (en) Digital and user interfaces for analyte monitoring systems
JP5594935B2 (ja) 生理的特徴のモニタリングのためのシステム
HK1247541A1 (zh) 在人体上测量的参数的可视化
EP2471456A1 (fr) Système de contrôle de caractéristiques physiologiques
CN113164075B (zh) 一种监护设备的报警限值设置方法及装置
CN105451639A (zh) 用于显示暂时血氧水平的界面
EP3111831B1 (fr) Dispositif portable et procédé de traitement de surveillance continue des données indicatives d'un analyte dans un fluide corporel, système médical et produit de programme informatique
CN116369849A (zh) 一种监护设备及其报警阈值的设置指引方法
EP3179901B1 (fr) Lecteur de glycémie à interface utilisateur peu coûteuse comprenant des indicateurs graphiques programmés
CN112911992A (zh) 监护方法、监护仪及计算机存储介质
WO2004056264A1 (fr) Affichage graphique pour dispositifs medicaux
JP2020092813A (ja) 生体情報システム
EP4598008A1 (fr) Procédé d'affichage d'informations de surveillance, système de surveillance et dispositif associé
WO2014008342A1 (fr) Dispositif d'affichage d'informations d'analyte de patient
CN118201549A (zh) 用于显示生理传感器的阻抗信息的系统和方法
HK1242550A1 (en) Blood glucose meter with low cost user interface having programmed graphic indicators
HK1139848A (en) Visualization of a parameter which is measured on the human body
HK1242550B (zh) 带有具有经编程的图形指示符的低成本用户接口的血糖仪

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP